IL18 and neoplasm: The subcutaneous tumors that developed in the latter group showed delayed onset and were significantly smaller (p = 0.0002) at necropsy compared to those given αIL-18 (Fig. 1 B), indicating that IL-18 not only prevented tumor formation but also suppressed the growth of those that developed.